Jim Cramer calls Nuvation Bio a "pure spec" and favors CoreWeave among neoclouds
AI Summary- Jim Cramer assessed Nuvation Bio, IREN, Seneca Foods, NuScale, GE Vernova and Box.
- $321.100 million was Box’s reported quarterly sales, above the $319.331 million consensus estimate.
- Nuvation Bio received Fast Track Designation for safusidenib on Aug. 20, according to the source.